Metabolic profile of amniotic fluid as a biochemical tool to screen for inborn errors of metabolism and fetal anomalies
- 12 August 2011
- journal article
- Published by Springer Science and Business Media LLC in Molecular and Cellular Biochemistry
- Vol. 359 (1-2), 205-216
- https://doi.org/10.1007/s11010-011-1015-y
Abstract
Physiologic concentration in amniotic fluid (AF) of several metabolites has not been established with certainty. In this study, we initially assayed purines, pyrimidines, and amino compounds in 1,257 AF withdrawn between the 15th and the 20th week of gestation from actually normal pregnancies (normal gestations, normal offspring). Results allowed to determine physiologic reference intervals for 45 compounds. In these AF, not all purines and pyrimidines were detectable and uric acid (238.35 ± 76.31 μmol/l) had the highest concentration. All amino compounds were measurable, with alanine having the highest concentration (401.10 ± 88.47 μmol/l). In the second part of the study, we performed a blind metabolic screening of AF to evaluate the utility of this biochemical analysis as an additional test in amniocenteses. In 1,295 additional AF from normal pregnancies, all metabolites fell within the confidence intervals determined in the first part of the study. In 24 additional AF from women carrying Down’s syndrome-affected fetuses, glutamate, glutamine, glycine, taurine, valine, isoleucine, leucine, ornithine, and lysine were different from physiologic reference values. One AF sample showed phenylalanine level of 375.54 μmol/l (mean value in normal AF = 65.07 μmol/l) and was from a woman with unreported phenylketonuria with mild hyperphenylalaninemia (serum phenylalanine = 360.88 μmol/l), carrying the IVS 4 + 5 G-T and D394A mutations. The fetus was heterozygote for the maternal D394A mutation. An appropriate diet maintained the mother phenylalanine in the range of normality during pregnancy, avoiding serious damage in fetal and neonatal development. These results suggest that the metabolic screening of AF might be considered as an additional biochemical test in amniocenteses useful to highlight anomalies potentially related to IEM.Keywords
This publication has 26 references indexed in Scilit:
- Impact of Prenatal Disorders on the Metabolic Profile of Second Trimester Amniotic Fluid: A Nuclear Magnetic Resonance Metabonomic StudyJournal of Proteome Research, 2010
- Gestational age‐related reference values for amniotic fluid organic acidsPrenatal Diagnosis, 2009
- Quantitative metabolic profiles of 2nd and 3rd trimester human amniotic fluid using 1H HR-MAS spectroscopyMagnetic Resonance Materials in Physics, Biology and Medicine, 2009
- Identification and quantitation of human amniotic fluid components using capillary zone electrophoresisAnalytical Biochemistry, 2009
- Second trimester amniotic fluid transferrin and uric acid predict infant birth outcomesPrenatal Diagnosis, 2008
- Metabolite Profiling of Human Amniotic Fluid by Hyphenated Nuclear Magnetic Resonance SpectroscopyAnalytical Chemistry, 2008
- Uric acid changes in urine and plasma: An effective tool in screening for purine inborn errors of metabolism and other pathological conditionsJournal of Inherited Metabolic Disease, 2007
- Amino acids in amniotic fluid in the 15th–16thweeks of gestation and preterm laborThe Journal of Maternal-Fetal & Neonatal Medicine, 2007
- Economic evaluation of neonatal screening for phenylketonuria and congenital hypothyroidismJournal of Paediatrics and Child Health, 2005
- Effect of high maternal blood phenylalanine on offspring congenital anomalies and developmental outcome at ages 4 and 6 years: the importance of strict dietary control preconception and throughout pregnancyThe Journal of Pediatrics, 2004